100 results
Page 3 of 5
8-K
2kko1zz8
13 Jan 20
PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension
4:07pm
S-3
EX-1.2
6o2tghfdh0 jt5
27 Dec 19
Shelf registration
5:28pm
S-3
EX-4.2
kpx1ntcp2c
27 Dec 19
Shelf registration
5:28pm
S-3
4kptq01
27 Dec 19
Shelf registration
5:28pm
8-K
EX-10.1
fstt4z 41
9 Apr 19
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
8:01am
DEF 14A
zj3qwu9ertg1wc8f1kjg
5 Apr 19
Definitive proxy
4:05pm
10-K
EX-4.4
6znv2pn id5eo46650x
26 Mar 19
Annual report
4:45pm
10-K
EX-10.13
lwnmppibj7y2
26 Mar 19
Annual report
4:45pm
10-K
EX-10.14
kh8 m5x9n
26 Mar 19
Annual report
4:45pm